Entera Bio Ltd. expects an operating loss of between $25 and $30 million for the year ending December 31, 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.06 USD | -2.37% | -0.96% | +243.33% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+243.33% | 73.78M | |
+15.85% | 122B | |
+18.91% | 113B | |
+7.57% | 22.84B | |
-18.63% | 20.72B | |
-15.57% | 16.51B | |
-13.76% | 16.39B | |
-43.53% | 15.83B | |
+1.75% | 13.49B | |
+28.07% | 11.67B |
- Stock Market
- Equities
- ENTX Stock
- News Entera Bio Ltd.
- Entera Bio Ltd. Provides Earnings Guidance for the Year Ending December 31, 2022